文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

邻里社会脆弱性与卵巢癌生存率的关联。

Association of neighborhood social vulnerability with ovarian cancer survival.

作者信息

Borho Lauren, Elishaev Esther, Bao Riyue, O'Brien Emily, Dinkins Kaitlyn, Berger Jessica, Boisen Michelle, Comerci John, Courtney-Brooks Madeleine, Edwards Robert P, Garrett Alison Aunkst, Kelley Joseph L, Lesnock Jamie, Mahdi Haider S, Olawaiye Alexander, Rush Shannon, Sukumvanich Paniti, Taylor Sarah, Aneja Ritu, Norian Lyse, Arend Rebecca C, Modugno Francesmary

机构信息

Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine and Magee-Womens Research Institute and Foundation, Pittsburgh, PA, United States of America.

Department of Pathology, University of Pittsburgh School of Medicine and Magee-Womens Research Institute and Foundation, Pittsburgh, PA, United States of America.

出版信息

Gynecol Oncol. 2025 Jan;192:32-39. doi: 10.1016/j.ygyno.2024.10.030. Epub 2024 Nov 21.


DOI:10.1016/j.ygyno.2024.10.030
PMID:39577071
Abstract

OBJECTIVE: Social determinants of health (SDOH) impact cancer outcomes. The CDC Social Vulnerability Index (SVI) integrates scores for four neighborhood-based SDOH domains (socioeconomic status, household characteristics, minority status, and housing type/transportation) to assess neighborhood social vulnerability (NSV). While NSV has been associated with overall cancer mortality and lung, breast, colon, and endometrial cancer-specific mortality, the relationship between NSV as defined by the SVI and ovarian cancer outcomes remains unknown. METHODS: We used data from 177 patients enrolled in an observational ovarian cancer cohort study from October 2012 through September 2022. All patients underwent debulking surgery and completed an entire course of standard-of-care platinum-based chemotherapy. Follow-up was completed through May 2024. SVI was calculated using census tract at diagnosis. High NSV was defined as SVI in the top quartile of the cohort. Cox proportional hazard models assessed the association between NSV and progression-free (PFS) and overall (OS) survival. RESULTS: After accounting for demographic and clinical factors, high NSV was associated with significantly worse PFS (HR:2.31 [95% CI:1.48-3.61]; P < 0.001) and OS (HR:1.79 [95% CI:1.10-2.92]; P = 0.02), with neighborhood socioeconomic status associated with significantly worse PFS (HR:2.29 [95% CI:1.47-3.56]; P < 0.001) and OS (HR:1.71 [95% CI:1.04-2.80]; P = 0.03). Neighborhood housing type/transportation was also associated with significantly worse PFS (HR:1.65 [95% CI:1.07-2.55]; P = 0.02) and trended towards worse OS (HR:1.43 [95% CI: 0.80-2.33]). CONCLUSION AND RELEVANCE: Higher neighborhood social vulnerability is associated with worse outcomes among ovarian cancer patients. Validating these results in a population-based cohort and assessing programs to reduce neighborhood social vulnerability to improve ovarian cancer outcomes is warranted.

摘要

目的:健康的社会决定因素(SDOH)会影响癌症预后。美国疾病控制与预防中心的社会脆弱性指数(SVI)整合了四个基于社区的SDOH领域(社会经济地位、家庭特征、少数族裔地位以及住房类型/交通状况)的得分,以评估社区社会脆弱性(NSV)。虽然NSV已被证明与总体癌症死亡率以及肺癌、乳腺癌、结肠癌和子宫内膜癌的特定癌症死亡率有关,但SVI所定义的NSV与卵巢癌预后之间的关系仍然未知。 方法:我们使用了2012年10月至2022年9月期间纳入一项卵巢癌观察性队列研究的177例患者的数据。所有患者均接受了肿瘤细胞减灭术,并完成了整个疗程的标准铂类化疗。随访至2024年5月结束。使用诊断时的普查区计算SVI。高NSV定义为SVI处于队列的前四分位数。Cox比例风险模型评估了NSV与无进展生存期(PFS)和总生存期(OS)之间的关联。 结果:在考虑了人口统计学和临床因素后,高NSV与显著更差的PFS(风险比:2.31 [95%置信区间:1.48 - 3.61];P < 0.001)和OS(风险比:1.79 [95%置信区间:1.10 - 2.92];P = 0.02)相关,其中社区社会经济地位与显著更差的PFS(风险比:2.29 [95%置信区间:1.47 - 3.56];P < 0.001)和OS(风险比:1.71 [95%置信区间:1.04 - 2.80];P = 0.03)相关。社区住房类型/交通状况也与显著更差的PFS(风险比:1.65 [95%置信区间:1.07 - 2.55];P = 0.02)相关,并且OS有变差的趋势(风险比:1.43 [95%置信区间:0.80 - 2.33])。 结论及意义:社区社会脆弱性较高与卵巢癌患者预后较差相关。有必要在基于人群的队列中验证这些结果,并评估旨在降低社区社会脆弱性以改善卵巢癌预后的项目。

相似文献

[1]
Association of neighborhood social vulnerability with ovarian cancer survival.

Gynecol Oncol. 2025-1

[2]
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.

Cochrane Database Syst Rev. 2022-9-26

[3]
All-cause mortality and neighborhood social vulnerability among women with ovarian cancer.

Gynecol Oncol. 2025-4

[4]
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.

Cochrane Database Syst Rev. 2022-7-12

[5]
Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer.

Cochrane Database Syst Rev. 2022-2-16

[6]
Optimal primary surgical treatment for advanced epithelial ovarian cancer.

Cochrane Database Syst Rev. 2011-8-10

[7]
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.

Cochrane Database Syst Rev. 2017-9-13

[8]
Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.

Cochrane Database Syst Rev. 2022-8-30

[9]
Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with epithelial ovarian cancer.

Cochrane Database Syst Rev. 2022-2-21

[10]
Systemic treatments for metastatic cutaneous melanoma.

Cochrane Database Syst Rev. 2018-2-6

引用本文的文献

[1]
Association of social vulnerability with access to treatment in ovarian cancer patients.

Gynecol Oncol Rep. 2025-7-20

本文引用的文献

[1]
Social Determinants of Health and Cancer Care: An ASCO Policy Statement.

JCO Oncol Pract. 2024-5

[2]
Cancer statistics, 2024.

CA Cancer J Clin. 2024

[3]
Impact of Treatment Delay on the Prognosis of Patients with Ovarian Cancer: A Population-based Study Using the Surveillance, Epidemiology, and End Results Database.

J Cancer. 2024-1-1

[4]
Social vulnerability and lung malignancy mortality.

J Cancer Policy. 2023-12

[5]
Health Disparities in Ovarian Cancer: Report From the Ovarian Cancer Evidence Review Conference.

Obstet Gynecol. 2023-7-1

[6]
Role of neighborhood context in ovarian cancer survival disparities: current research and future directions.

Am J Obstet Gynecol. 2023-10

[7]
The social vulnerability index as a risk stratification tool for health disparity research in cancer patients: a scoping review.

Cancer Causes Control. 2023-5

[8]
Factor Analysis of Health Care Access With Ovarian Cancer Surgery and Gynecologic Oncologist Consultation.

JAMA Netw Open. 2023-2-1

[9]
The Geographic Context of Racial Disparities in Aggressive Endometrial Cancer Subtypes: Integrating Social and Environmental Aspects to Discern Biological Outcomes.

Int J Environ Res Public Health. 2022-7-15

[10]
Social vulnerability is associated with increased morbidity following colorectal surgery.

Am J Surg. 2022-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索